(Q73179490)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11074355%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Prevention of bone loss by EM-800 and raloxifene in the ovariectomized rat (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11074355%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

C Martel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11074355%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

S Picard

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11074355%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

V Richard

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11074355%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A Bélanger

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11074355%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

C Labrie

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11074355%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

F Labrie

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11074355%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 September 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11074355%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Steroid Biochemistry and Molecular Biology

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11074355%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11074355%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11074355%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

45-56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11074355%20AND%20SRC:MED&resulttype=core&format=json

Determinants of bone density in normal women: risk factors for future osteoporosis?

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

Menopause and risk factors for coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

Menopause and coronary heart disease. The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

Evaluating the benefits and risks of postmenopausal hormone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

Estrogen replacement therapy: indications and complications

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

Association of Exogenous Estrogen and Endometrial Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

The risk of breast cancer after estrogen and estrogen-progestin replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

Effects of tamoxifen on cardiovascular risk factors in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

A controlled trial of raloxifene (LY139481) HCl: impact on bone turnover and serum lipid profile in healthy postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

Activity of raloxifene in immature and ovariectomized rat uterotrophic assays

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

(S)-(+)-4-[7-(2,2-dimethyl-1-oxopropoxy)-4-methyl-2-[4-[2-(1-piperidinyl)-ethoxy]phenyl]-2H-1-benzopyran-3-yl]-phenyl 2,2-dimethylpropanoate (EM-800): a highly potent, specific, and orally active nonsteroidal antiestrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

Comparative effects of 28-day treatment with the new anti-estrogen EM-800 and tamoxifen on estrogen-sensitive parameters in intact mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

Long-term inhibitory effects of a novel anti-estrogen on the growth of ZR-75-1 and MCF-7 human breast cancer tumors in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

Binding characteristics of novel nonsteroidal antiestrogens to the rat uterine estrogen receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

Characterization of the effects of the novel non-steroidal antiestrogen EM-800 on basal and estrogen-induced proliferation of T-47D, ZR-75-1 and MCF-7 human breast cancer cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

Morphological changes induced by 6-month treatment of intact and ovariectomized mice with tamoxifen and the pure antiestrogen EM-800.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

Predominant androgenic component in the stimulatory effect of dehydroepiandrosterone on bone mineral density in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

Embedding Iliac Bone Biopsies at Low Temperature using Glycol and Methyl Methacrylates

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

Bone embedding in pure methyl methacrylate at low temperature preserves enzyme activities

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

Pathophysiological mechanisms of estrogen effect on bone metabolism. Dose-response relationships in early postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

Progestin regulation of cellular proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

The menopause: health implications and clinical management

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

Hormone therapy to prevent disease and prolong life in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

Clinical review 27: Effects of hormonal replacement on lipids and lipoproteins in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

Hormone replacement therapy for prevention and treatment of osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

Preventive effects of transdermal 17 beta-estradiol on osteoporotic changes after surgical menopause: a two-year placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

The cellular basis of bone remodeling: the quantum concept reexamined in light of recent advances in the cell biology of bone

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

A comparative study of the actions of tamoxifen, estrogen and progesterone in the ovariectomized rat

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

Estrogen Treatment Prevents Osteopenia and Depresses Bone Turnover in Ovariectomized Rats*

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

Antagonism of estrogen action with a new benzothiophene derived antiestrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

Antiestrogenic properties of raloxifene

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

Combined effects of dehydroepiandrosterone and EM-800 on bone mass, serum lipids, and the development of dimethylbenz(A)anthracene-induced mammary carcinoma in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

Inhibitory effect of the novel anti-estrogen EM-800 and medroxyprogesterone acetate on estrone-stimulated growth of dimethylbenz[a]anthracene-induced mammary carcinoma in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

Prevention of development of dimethylbenz(a)anthracene (DMBA)-induced mammary tumors in the rat by the new nonsteroidal antiestrogen EM-800 (SCH57050).

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

Effect of dehydroepiandrosterone and the antiestrogen EM-800 on growth of human ZR-75-1 breast cancer xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

Bone density of the radius, spine, and proximal femur in osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

Effect of estrogens on rat serum cholesterol concentrations: consideration of dose, type of estrogen, and treatment duration

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900087-X

7 January 2021

10.1016/S0960-0760(00)00087-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11074355%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference